C12N 2760/18361
Methods of inactivation or attenuation
C12N2760/18361 (Methods of inactivation or attenuation) appears on 6 US grants and 14 published applications in this corpus.
Search patents in C12N- Granted patents
- 6
- Published applications
- 14
- Assignees
- 16
- Inventors
- 45
- Latest grant
- 18 Feb 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 1 | 1 |
| 2004 | 0 | 1 |
| 2005 | 0 | 1 |
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 2 |
| 2010 | 2 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 0 | 1 |
| 2016 | 0 | 0 |
| 2017 | 1 | 1 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 1 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 1 | 3 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Methods and compositions for treating negative-sense single-stranded RNA virus18 Feb 2025US 12,227,769 B2Nationwide Children's Hospital, Inc.
- Paramyxovirus immunogens and related materials and methods21 Feb 2017US 9,572,876 B2Ohio State Innovation Foundation
- Recombinant human metapneumovirus and its use27 Apr 2010US 7,704,491 B2The United States of America as represented by the Department of Health and Human Services
- Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus27 Apr 2010US 7,704,720 B2MedImmune, LLC
- Avian pneumovirus vaccine12 Aug 2003US 6,605,460 B1University of Minnesota
- Avian metapneumovirus isolates and immunogenic compositions therefrom20 Aug 2026US 2026/0240983 A1Iowa State University Research Foundation, Inc.
- Methods and compositions for treating negative-sense single-stranded rna virus7 Aug 2025US 2025/0250548 A1Nationwide Children's Hospital, Inc.
- Vaccine composition against two respiratory viruses19 Jun 2025US 2025/0195637 A1
- Multivalent vaccine for paramyxoviruses and uses thereof22 May 2025US 2025/0161436 A1Icosavax, Inc.
- Methods and compositions for treating negative-sense single-stranded rna virus3 Feb 2022US 2022/0033783 A1Nationwide Children's Hospital, Inc.
Most cited
By later US patents
- Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus27US 7,704,720 B2MedImmune, LLC · 2010
- Method for the culture of the TRT/SHS virus, and vaccine therefrom, especially for the treatment of turkeys22US 4,810,493 AMinistere de l'Agriculture Direction de la Qualite Services Veterinaires Laboratoire National de Pathologie Aviaire · 1989
- Recombinant human metapneumovirus and its use9US 7,704,491 B2The United States of America as represented by the Department of Health and Human Services · 2010
- Avian pneumovirus vaccine3US 6,605,460 B1University of Minnesota · 2003